Frank J. Gonzalez

149.8k citations
1.3k papers · 119.2k indexed · 42 hit papers · h-index 171
Topics
Pharmacogenetics and Drug Metabolism (379 papers)Peroxisome Proliferator-Activated Receptors (322 papers)Drug Transport and Resistance Mechanisms (306 papers)
Partner nations
United StatesJapanChina

In The Last Decade

Frank J. Gonzalez

1.3k papers receiving 116.5k citations

Hit Papers

Targeted Disruption of the Nuclear Receptor FXR/BAR Impai...1987202620002013200019951993199919874008001.2k

Peers

Frank J. Gonzalez
Comparison fields: 5 of 196
  • Molecular Biology 56.6k
  • Pharmacology 31.3k
  • Oncology 27.1k
  • Epidemiology 19.1k
  • Physiology 16.8k
Replace Ronald M. Evans with:
Ronald M. Evans United States
Michael Karin United States
Timothy M. Willson United States
Steven A. Kliewer United States
F. Peter Guengerich United States
Masayuki Yamamoto Japan
Barry Halliwell United Kingdom
Bart Staels France
Jan-Ακε Gustafsson Sweden
David J. Mangelsdorf United States
Frank J. Gonzalez relative to Ronald M. Evans United States Ronald M. Evans's profile →
Citations per field
00.5×5.6×
Ronald M. Evans · 1×
Citations per year

Countries citing papers authored by Frank J. Gonzalez

Since Specialization
Citations

This map shows the geographic impact of Frank J. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank J. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank J. Gonzalez more than expected).

Fields of papers citing papers by Frank J. Gonzalez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank J. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank J. Gonzalez. The network helps show where Frank J. Gonzalez may publish in the future.

Co-authorship network of co-authors of Frank J. Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of Frank J. Gonzalez. A scholar is included among the top collaborators of Frank J. Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank J. Gonzalez. Frank J. Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 2
4 4
5 8
6 14
7 68
8 17
9 45
10 13
11 1
12 10
13 142
14 54
15 224
16 256
17 48
18 111
19 402
20 437

About Frank J. Gonzalez

Frank J. Gonzalez is a scholar working on Pharmacology, Biochemistry and Cancer Research, having authored 1.3k papers that have together received 119.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (379 papers), Peroxisome Proliferator-Activated Receptors (322 papers) and Drug Transport and Resistance Mechanisms (306 papers). The work is most often cited by research in Pharmacology (31.3k citations), Biochemistry (10.3k citations) and Cancer Research (15.7k citations). Frank J. Gonzalez has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Daniel W. Nebert, Jeffrey M. Peters, Kristopher W. Krausz, Jerrold M. Ward, Harry V. Gelboin, Pedro M. Fernández‐Salguero, Shioko Kimura, Jeffrey R. Idle, Yatrik M. Shah and Andrew D. Patterson. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026